Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2026-04-13 @ 12:11 PM
Study NCT ID:
NCT06110793
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2023-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
23-274
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |